Decrease in choroidal blood flow after half and one-third dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy

BACKGROUND: The effect of various reduced doses of verteporfin photodynamic therapy (PDT) on choroidal blood flow in chronic central serous chorioretinopathy (CSC) remains unclear. Therefore, this study aimed to evaluate choroidal blood flow after half-dose PDT (1/2PDT) and one-third dose PDT (1/3PD...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Ophthalmol
Hlavní autoři: Kumashiro, Shun, Takagi, Seiji, Itokawa, Takashi, Tajima, Akiko, Kobayashi, Tatsuhiko, Hori, Yuichi
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8165776/
https://ncbi.nlm.nih.gov/pubmed/34053440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-021-01980-w
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky